Literature DB >> 12459501

Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells.

Nicolas André1, Manon Carré, Gaël Brasseur, Bertrand Pourroy, Hervé Kovacic, Claudette Briand, Diane Braguer.   

Abstract

We previously reported that paclitaxel acted directly on mitochondria isolated from human neuroblastoma SK-N-SH cells. Here, we demonstrate that the direct mitochondrial effect of paclitaxel observed in vitro is relevant in intact SK-N-SH cells. After a 2 h incubation with 1 microM paclitaxel, the mitochondria were less condensed. Paclitaxel (1 microM, 1-4 h) also induced a 20% increase in respiration rate and a caspase-independent production of reactive oxygen species by mitochondria. The paclitaxel-induced release of cytochrome c was detected only after 24 h of incubation, was caspase-independent and permeability transition pore-dependent. Thus, paclitaxel targets mitochondria upstream of caspase activation, early during the apoptotic process in intact human neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459501     DOI: 10.1016/s0014-5793(02)03691-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Comparison of cell death-inducing effect of novel taxane SB-T-1216 and paclitaxel in breast cancer cells.

Authors:  Jan Kovár; Marie Ehrlichová; Barbora Smejkalová; Ilaria Zanardi; Iwao Ojima; Ivan Gut
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

2.  Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting.

Authors:  Swati Biswas; Namita S Dodwadkar; Rupa R Sawant; Alexander Koshkaryev; Vladimir P Torchilin
Journal:  J Drug Target       Date:  2011-02-25       Impact factor: 5.121

3.  Prognostic significance of the mitochondrial scoring system in ovarian cancer.

Authors:  Ryuma Matsumoto; Seiji Isonishi; Kazuhiko Ochiai; Tomomi Hamada; Takako Kiyokawa; Toshiaki Tachibana; Hiroshi Ishikawa
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

Review 4.  Targeting mitochondria for cancer therapy.

Authors:  Simone Fulda; Lorenzo Galluzzi; Guido Kroemer
Journal:  Nat Rev Drug Discov       Date:  2010-05-14       Impact factor: 84.694

5.  Vasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxel.

Authors:  N G Gracias; T R Cummins; M R Kelley; D P Basile; T Iqbal; M R Vasko
Journal:  Neurotoxicology       Date:  2010-10-07       Impact factor: 4.294

6.  Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells: regulation by free tubulin and erastin.

Authors:  Eduardo N Maldonado; Kely L Sheldon; David N DeHart; Jyoti Patnaik; Yefim Manevich; Danyelle M Townsend; Sergey M Bezrukov; Tatiana K Rostovtseva; John J Lemasters
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

7.  Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.

Authors:  Vaikunth Cuchelkar; Pavla Kopecková; Jindrich Kopecek
Journal:  Mol Pharm       Date:  2008-09-04       Impact factor: 4.939

8.  SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.

Authors:  Xiaoling Zhao; Weimin Kong; Katherine Tucker; Allison Staley; Yali Fan; Wenchuan Sun; Yajie Yin; Yu Huang; Ziwei Fang; Jiandong Wang; Somdutta Sen; Sundeep Dugar; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Transl Res       Date:  2020-08-15       Impact factor: 4.060

9.  Bcl-2-enhanced efficacy of microtubule-targeting chemotherapy through Bim overexpression: implications for cancer treatment.

Authors:  Amandine Savry; Manon Carre; Raphael Berges; Amandine Rovini; Isabelle Pobel; Christine Chacon; Diane Braguer; Véronique Bourgarel-Rey
Journal:  Neoplasia       Date:  2013-01       Impact factor: 5.715

10.  Betulinic Acid for cancer treatment and prevention.

Authors:  Simone Fulda
Journal:  Int J Mol Sci       Date:  2008-06-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.